- Home
- SCNX vs ZYXI Comparison
SCNX vs ZYXI Comparison
Compare SCNX & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- ZYXI
- Stock Information
- Founded
- SCNX 2010
- ZYXI 1996
- Country
- SCNX United States
- ZYXI United States
- Employees
- SCNX N/A
- ZYXI N/A
- Industry
- SCNX Other Pharmaceuticals
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SCNX Health Care
- ZYXI Health Care
- Exchange
- SCNX Nasdaq
- ZYXI Nasdaq
- Market Cap
- SCNX 31.5M
- ZYXI 35.8M
- IPO Year
- SCNX 2020
- ZYXI N/A
- Fundamental
- Price
- SCNX $0.59
- ZYXI $1.67
- Analyst Decision
- SCNX
- ZYXI Hold
- Analyst Count
- SCNX 0
- ZYXI 3
- Target Price
- SCNX N/A
- ZYXI $3.00
- AVG Volume (30 Days)
- SCNX 16.4M
- ZYXI 13.4M
- Earning Date
- SCNX 11-13-2025
- ZYXI 11-17-2025
- Dividend Yield
- SCNX N/A
- ZYXI N/A
- EPS Growth
- SCNX N/A
- ZYXI N/A
- EPS
- SCNX N/A
- ZYXI N/A
- Revenue
- SCNX $653,391.00
- ZYXI $108,202,000.00
- Revenue This Year
- SCNX N/A
- ZYXI N/A
- Revenue Next Year
- SCNX N/A
- ZYXI $7.07
- P/E Ratio
- SCNX N/A
- ZYXI N/A
- Revenue Growth
- SCNX 207.88
- ZYXI N/A
- 52 Week Low
- SCNX $0.46
- ZYXI $0.38
- 52 Week High
- SCNX $8.72
- ZYXI $8.72
- Technical
- Relative Strength Index (RSI)
- SCNX 44.06
- ZYXI 70.58
- Support Level
- SCNX $0.50
- ZYXI $0.38
- Resistance Level
- SCNX $0.62
- ZYXI $0.88
- Average True Range (ATR)
- SCNX 0.06
- ZYXI 0.26
- MACD
- SCNX -0.00
- ZYXI 0.07
- Stochastic Oscillator
- SCNX 31.62
- ZYXI 84.34
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.